Global
Hospital
Microbiology Testing Market is expected to witness lucrative growth
over the forecast period owing to increase in awareness levels of people
related to onset of respiratory infections along with other chronic problems
such as inflammatory disorders. Efficacy and availability of anti-viral
treatments for diseases such as periodontitis, gingivitis, Chronic Pulmonary
Obstructive Disease (COPD), and rise in sex-related awareness amongst the
population in developing countries are the major drivers for the growth of the
market. Increase in economic conditions along with various reimbursement
policies, development of new hospital microbiology testing industry due to
technological advancements, and increased investment in the companies are some
other factors fueling the expansion of the hospital microbiology testing
market. Various immunoassay techniques are implemented for rapid diagnosis of
infection with accuracy that further leads to potential diagnostic platform and
technologies such as biochemical tests, microbial culture, and molecular
diagnostics. Diseases such as HIV, Human Papilloma Virus (HPV), and Hepatitis B
and C are forms of STDs that are severe and fatal, therefore increasing the
demand for the hospital microbiology testing market. Increasing healthcare
expenditure and presence of better medical infrastructures such as hospitals
and clinical labs are some other drivers of the augmentation in the market.
Hospital
microbiology testing industry is segmented on the basis of procedure, products,
and applications. Microbial culture, microscopy, biochemical tests, and
molecular diagnostics are the procedure segments of the hospital microbiology
testing market. On the basis of products, the segments are consumables and
instruments. Consumables are further segmented into reagents and kits. Kits
occupy the major market share amongst consumables owing to its rise in utility
by healthcare and diagnostic centers. Instruments are sub-segmented into
microbiology analyzers, automated microbiology instruments, and microbiology
analyzers. It is estimated that automated microbiology instruments will
experience a rapid growth over the forecast period. Microbiology analyzers are
segmented into microscopes, molecular diagnostic instruments, and mass
spectrometers. Mass spectrometers are expected to experience a speedy
development due to rise in acceptance of the device as well as increasing
efficiency. On the basis of applications, the market is segmented into
respiratory diseases, periodontal diseases, sexually transmitted infections,
and urinary tract infections. The major market share is covered by respiratory
diseases owing to rise in inflammatory diseases as a result of increase in
pollution in the surroundings along with certain chronic diseases such as
asthma.
Based
on geography, the hospital microbiology testing market is segmented into North
America, Europe, Asia Pacific, Latin America, and MEA. In 2014, North-America
held the largest market share in terms of revenue followed by Europe. Rising
prevalence of various diseases among the population, sophisticated healthcare
infrastructure, and growing need for advanced diagnostic testing are the key
reasons behind North-America being the market leader. Developing economies of
Asia Pacific such as India, China, and Brazil are expected to experience a
favorable expansion over the forecast period. This is attributed to the tax
benefits, favorable reimbursement scenario, and increasing medical tourism in
these nations. Moreover, prevalence and severity of diseases in emerging
nations such as India, China, Indonesia, and Malaysia propels the growth in the
region.
The
Centers for Disease Control and Prevention (CDC) estimate that as many as 2
million hospital-acquired infections occur in the U.S. hospital each year,
which are associated with more than 90,000 deaths. The Public Health England
(PHE) scientists investigated an incident in late 2011 and early 2012, where
infections associated with Pseudomonas aeruginosa caused the deaths of four
neonates in Northern Ireland. Data from the Bureau of Labor Statistics
estimated a 17% annual growth rate in clinical laboratory jobs and that 53,000
new jobs were created in this sector from 1998 through 2008.
Some
key players of the hospital microbiology testing market are Quidel Corporation,
Dickinson and company, F. Hoffmann-La Roche Ltd., Thermo-Fischer Scientific,
Inc., Gen-Probe, Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc.,
Siemens Healthcare Diagnostics, Inc., and Sysmex Corporation.
About Us:Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment